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The most common site for skeletal metastases requiring sur-
gical intervention is the proximal femur, which accounts for 
approximately 65% of all cases. In contrast, the tibia accounts 
for only 3% of pathological fractures requiring surgery, mostly 
commonly in the proximal third (Ratasvuori et al. 2013). Due 
to the proximity of the knee joint and the poor soft tissue enve-
lope in the proximal tibia, the management of metastatic depos-
its and pathological fractures in this region can be challenging. 
Given the scarcity of this metastasis location, there is a pau-
city of evidence relating to the outcomes of surgical treatment 
of pathological fractures of the proximal tibia. In this retro-
spective case series we assessed the advantages and disadvan-
tages of different surgical reconstructions, looking in particu-
lar at implant survival, the incidence of complications, and the 
possible factors that may affect these outcomes. 
Patients and methods
The study comprised a retrospective analysis of all patients 
treated for a complete or pending pathological fracture arising 
within the proximal tibia treated at 1 of 4 international col-
laborative hospitals: Helsinki University Hospital, Helsinki, 
Finland;, Coxa Hospital for Joint replacement, Tampere, Fin-
land; Karolinska University Hospital, Stockholm, Sweden; 
and Royal Orthopaedic Hospital, Birmingham, UK. The study 
population comprised 74 patients treated between 2000 and 
2018. All patients over 18 years of age with histologically 
confirmed metastatic bone disease of any primary malignancy, 
including multiple myeloma and lymphoma, were included. 
The decision to undergo surgical intervention was discussed 
Background and purpose — The proximal tibia is a rare 
site for metastatic bone disease and is a challenging anatomi-
cal site to manage due to the proximity to the knee joint and 
poor soft tissue envelope. We investigated implant survival 
and complications of different surgical strategies in the treat-
ment of proximal tibia pathological fractures.
Patients and methods — The study comprised a 4 
medical center, retrospective analysis of 74 patients surgi-
cally treated for metastases of the proximal tibia. Patient 
records were reviewed to identify outcome, incidence, and 
type of complications as well as contributing factors.
Results — Reconstruction techniques comprised cement-
augmented osteosynthesis (n = 33), tumor prosthesis (n = 
31), and total knee arthroplasty with long cemented stems 
(n = 10). Overall implant survival was 88% at 6 months 
and 1 year, and 67% at 3 years. After stratification by tech-
nique, the implant survival was 82% and 71% at 1 and 3 
years with tumor prosthesis, 100% at 1 and 3 years with total 
knee arthroplasty, and 91% at 1 year and 47% at 3 years with 
osteosynthesis. Preoperative radiotherapy decreased implant 
survival. Complications were observed in 19/74 patients. 
Treatment complications led to amputation in 5 patients.
Interpretation — In this study, the best results were 
seen with both types of prothesis reconstructions, with good 
implant survival, when compared with treatment with osteo-
synthesis. However, patients treated with tumor prosthesis 
showed an increased incidence of postoperative infection, 
which resulted in poor implant survival. Osteosynthesis with 
cement is a good alternative for patients with short expected 
survival whereas endoprosthetic replacement achieved good 
medium-term results.
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at a multidisciplinary team conference at each of the 4 cen-
tres and was made following discussion between the operat-
ing surgeon and the patient. Preoperative radiological assess-
ment comprised plain radiographs in all cases, and in selected 
cases with computed tomography (CT) or magnetic resonance 
imaging (MRI). Systemic staging comprised CT scan of the 
chest, abdomen, and pelvis, and whole-body skeletal imaging 
in the form of radiolabelled technicium bone scan. 
Data was extracted from prospectively maintained insti-
tutional databases as well as medical records. Radiological 
assessment of relevant imaging was undertaken to assess eli-
gibility. Patient- and reconstruction-related outcome measures 
were recorded. A causal-directed acyclic graph (DAG) was 
used to investigate confounding factors (Figure 1).
The surgical treatment methods for impending or pathologi-
cal fracture were stratified into 1 of 3 possible reconstructions: 
tumor prosthesis, total knee arthroplasty (TKA) with long 
cemented stems, or osteosynthesis using plate and cement 
(Figure 2).
Postoperative complications, including mechanical compli-
cations, were defined according to the classification by Hen-
derson et al. (2014) (Table 1). Additionally, complications 
were defined as minor and major. Major complications were 
defined as those that required further surgical intervention. 
Minor complications were defined as those that did not require 
further surgical intervention. 
Statistics
Patient and implant survival rates were assessed using the 
Kaplan–Meier methods with 95% confidence intervals (CI). 
Between-group comparisons were performed using the log-
rank test. Patient follow-up time was calculated from the date 
of surgery to the most recent follow-up date or the date of 
death. Implant survival was calculated from the date of sur-
gery to revision surgery due to any cause. Continuous vari-
ables are reported as medians. The chi-squared test or Fisher’s 
exact test was used to compare variables between groups, and 
the Mann–Whitney U-test test for medians between groups. 
Subdistribution hazard ratio (SHR) of the role of factors 
affecting implant survival was calculated using competing risk 
analysis, where death was considered as a competing event. 
Statistical analyses were performed using SPSS Statistics 23.0 
(IBM Corp, Armonk, NY, USA) but competing risk analysis 
was performed using STATA 16 (StataCorp, College Station, 
TX, USA). A p-value < 0.05 was considered significant. 
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Results
The study population comprised 74 patients (45 men) with a 
median age at the time of surgery of 64 years (18–86). The 
median follow-up period was 12 months (0–210) and at final 
follow-up, 26 patients were alive. The most common primary 
malignancy was renal cell carcinoma (RCC, n = 29), followed 
by melanoma (8), colon cancer (6), breast cancer, sarcoma, 
lung cancer, and myeloma (5 cases each). Of the 74 patients, 
64 patients had an impending fracture and 10 patients had a 
complete fracture (Table 1). The overall mortality was 64% 
during the period of follow up. Overall patient survival after 
6 months was 74% (61–83), at 1 year 58% (46–70), and at 3 
years, 33% (21–45). Statistically significant factors negatively 
associated with survival were the incidence of a major com-
plication (p = 0.04) and the presence of an actual pathological 
fracture (p = 0.02).
Figure 1. Causal pathways in directed acyclic graphs in the variable 
selection. Exposure of interest = implant survival, outcome = implant 









Diagnosis AgeMetastatic load Sex
Expected
survival 
Figure 2. Surgical treatment methods: tumor prosthesis (A), total knee 
arthroplasty with long cemented stems (B), osteosynthesis using plate 
and cement (C).
   A    B    C
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Implant survival
The chosen reconstruction method is given in Table 1. Overall 
implant survival, regardless of reconstruction technique, was 
88% (80–97) after 6 months and 1 year, and 67% (50–83) at 3 
and 5 years (Figure 3). After stratifying by operative method, 
implant survival for the tumor prosthesis group was 93% (84–
100) at 6 months, 82% (67–96) at 1 year, and 71% (52–90) at 
3 and 5 years. In the osteosynthesis group, the implant sur-
vival was 91% (79–100) at 6 months and 1 year, and 47% 
(15–79) at 3 and 5 years. In the total knee arthroplasty (TKA) 
with long cemented stem group, implant survival was 100% 
after 6 months, 1, 3, and 5 years. The effect of preoperative 
radiotherapy and reconstruction technique on implant survival 
was analysed using a competing risk model. There was worse 
implant survival for the osteosynthesis group, but without sta-
tistical significance (p = 0.2) (Figure 4). Preoperative radio-
therapy had a significantly negative effect on implant survival 
compared with no preoperative radiotherapy in the tumor 
prosthesis and osteosynthesis groups (p = 0.004) (Figure 5). 
No other factors, identified by DAG, had a statistically signifi-
cant effect on implant survival.
Complications
Postoperative complications were seen in 19/74 patients. 
The most common was deep wound infection (8), followed 
by tumor progression (6), aseptic loosening or osteosynthesis 
failure of reconstruction/osteosynthesis (2), peroneal nerve 
paralysis (2), and fatal pulmonary embolus (1).
13/19 complications necessitated revision surgery (Tables 
2 and 3). 5 patients required subsequent amputation due to 
prosthetic joint infection (3) or tumor progression (2). In 3 
cases, further revision surgery was required to treat a peripros-
thetic joint infection, either by 2-stage revision in 2 cases, or 
by debridement, antibiotics, and implant retention (DAIR) in 
1 case. In 4 cases treated by osteosynthesis, the fixation failed, 
which required revision surgery in 2 cases. In the other 2 
cases, nonoperative management was advocated due to health 
deterioration. 3 patients treated with osteosynthesis suffered 
tumor progression and underwent revision surgery to a tumor 
prosthesis.
6/7 patients with postoperative periprosthetic joint infection 
(PJI) underwent revision surgery. 3/6 patients had received 
preoperative radiotherapy. All infections with preoperative 
Table 1. Patient characteristics (N = 74). 





 Renal cell carcinoma 29
 Melanoma   8
 Colon carcinoma   6
 Non-small-cell lung carcinoma   5
 Sarcoma   5
 Myeloma   5
 Breast carcinoma   5
 Prostate carcinoma   3
 Esophagus   2
 Bladder   2
 Lymphoma   2
 Retinoblastoma   1
 Squamocellular   1
Median age, years a 64 (18–86)
Mean follow-up, months a 12 (0–210)
Mean size, cma  6.3 (3–16)
Operative method
 Tumor prosthesis 31
 Total knee arthroplasty with 
    long cemented stems 10
 Osteosynthesis and cement 33
Complications 19
Complications according to 
   Henderson’s classification 18
 Type 1   2 
 Type 2   0
 Type 3   2
 Type 4   8 
 Type 5   6
Revision surgery 13
a Range in parenthesis
Table 2. Complications
  Osteo-  Permanent Fatal
  synthesis Tumor nerve pulmonary
Type Infection problem progression palsy embolism
Tumor prosthesis 8/11 0 1/11 2/11 0
TKA with long cemented stems 0 0 0 0 0
Osteosynthesis with cement 0 2/8 5/8 0 1/8
Table 3. Treatment of complications
  2-stage  Conversion to Re-osteo-
Type DAIR revision Amputation prosthesis synthesis
Tumor prosthesis 1/7 2/7 4/7 0 0
TKA with long cemented stems 0 0 0 0 0
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Figure 3. Implant survival. Figure 4. Implant survival 
stratified by surgical method 
in a competing risk model.
Figure 5. Implant survival 
stratified by radiotherapy in 
a competing risk model.
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radiotherapy occurred in the tumor prosthesis group. There 
were no infections in the osteosynthesis group (33 patients), 
despite a comparable incidence of preoperative radiotherapy. 
None of the 10 patients in TKA group underwent preoperative 
radiotherapy, and no postoperative infections requiring surgi-
cal intervention were seen. The outcome of patients who had 
received preoperative radiotherapy are summarized in Table 
4. The indication for amputation was infection (3) or tumor 
progression/recurrence (2). 4/5 patients requiring amputation 
underwent pre- or postoperative radiotherapy. 
Discussion
The literature describing the outcomes of proximal tibial path-
ological fractures is limited (Smolle et al. 2019), but what is 
known is that treatment complications are common for tumors 
in this location (Mavrogenis et al. 2013). The optimum method 
for reconstruction lacks consensus. 
Reconstruction of the proximal tibia using a tumor endo-
prosthesis is associated with a high rate of complication and 
failure (Smolle et al. 2019). Our study demonstrates that this 
is also true for patients treated with tumor prosthesis for MBD 
in the proximal tibia. Moreover, the complications were more 
severe when compared with patients treated with the other 
surgical methods studied. In particular, the risk of amputation 
due to infection was highest in patients treated with tumor 
prosthesis, and infection occurred in the early stages after the 
operation, consistent with reported findings for proximal tibial 
replacement following primary malignant bone tumor resec-
tion, where infection rates ranged between 6% and 44% (Flint 
et al. 2006, Myers et al. 2007, Wu et al. 2008, Schwartz et al. 
2010, Mavrogenis et al. 2013, Muller et al. 2016). Amputation 
is the most devastating complication following proximal tibia 
reconstruction surgery. In our study the rate of amputation 
after tumor prosthesis infection was 5/8, which is higher than 
previously reported in primary bone tumor studies with evi-
dently younger patients, where amputation rates due to infec-
tion were 5/12 in the study by Tsagozis et al. (2018) and 8/27 
in the study by Mavrogenis et al. (2013). The infection rate 
increases for the lifetime of the prosthesis due to the need for 
revision and servicing procedures, and can be as high as 87% 
(Ilyas et al. 2001, Grimer et al. 2002, Plotz et al. 2002, Jeys et 
al. 2005, Mavrogenis et al. 2011, Mavrogenis et al. 2015). The 
need for further revision procedures for proximal tibial tumor 
prosthesis was highlighted by Theil et al., who described the 
need for further procedures, including the management of 
infection, in 115/234 patients following a revision procedure 
(Theil et al. 2019). 
The short-term implant survival in the osteosynthesis group 
was similar to that seen in the endoprosthesis group. Several 
patients in this group developed complications requiring revi-
sion due to infection, failure of fixation, or tumor progression. 
The need for revision surgery in a plate-osteosynthesis group 
increases approximately 1 year after primary surgery. More-
over, due to comorbidities, some of these revision procedures 
were not undertaken. This may represent a selection bias for 
this method of reconstruction being used in patients in whom 
survival is considered to be short (less than a year). Due to the 
intralesional nature of this procedure, adjuvant local or sys-
temic treatment, aimed at reducing the risk of local recurrence 
or tumor progression, should be considered. 
We found the best results, in terms of implant survival or 
the need for revision surgery, in the cemented long-stemmed 
TKA group. However, it should be noted that the follow-up 
time in this patient group was the shortest. As was demon-
strated in the other groups, as follow-up increases, the risk 
of tumor progression increases and thus the need for further 
surgical intervention. This is reflected by the implant survival 
rate when studied with competing risk analysis. However, in 
the short term at least, the incidence of PJI in the long-stem 
TKA group appears not to present the same challenge as seen 
in the tumor prosthesis group. 
The increased risk of infection when undertaking procedures 
around the proximal tibia is well established and is at least in 
part due to the poor soft tissue envelope and the need for exten-
sive dissection to mobilize the proximal tibia. The introduction 
of gastrocnemius flaps to improve the soft tissue envelope has 
Table 4. Complications and radiotherapy
    Osteo-  Permanent Fatal
    synthesis Tumor nerve pulmonary
Type n Infection problem progression palsy embolism
Tumor prosthesis (n = 31)
 Preoperative radiotherapy 5 2 0 1 0 0
 No preoperative radiotherapy 26 6 0 0 2 0
TKA with long cemented stems (n = 10) 
 Preoperative radiotherapy 0 – – – – –
 No preoperative radiotherapy 10 0 0 0 0 0
Osteosynthesis with cement (n = 33) 
 Preoperative radiotherapy 7 0 1 1 0 0
 No preoperative radiotherapy 26 0 1 1 0 1
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resulted in a reduction in infections (Myers et al. 2007), but 
postoperative infection at this site remains higher than for other 
anatomical locations (Jeys et al. 2005). A gastrocnemius flap 
was used in all tumor prosthesis reconstructions in our study 
but, in spite of this, the infection rate remained higher when 
compared with that seen following resection and reconstruc-
tion of a primary malignant tumor of bone. In comparison with 
the study by Mavrogenis et al. (2013), where complications 
following proximal tibial replacement were seen in 56 of 225 
patients, and the infection rate was 27/225, we found complica-
tions in 17/74 patients, with an incidence of infection of 7/74. 
It is worthy of note that the median age of patients in our study 
was 64 years compared with 27 years in the study by Mavroge-
nis et al., which concerned primary malignant bone tumors. 
The role of radiotherapy in increasing complications is 
known (Theil et al. 2019). In our study, radiotherapy prior 
to tumor prosthesis further increased the risk of infection, 
despite the addition of a gastrocnemius flap. Radiotherapy 
leading to PJI often necessitates amputation to eradicate the 
infection (Mavrogenesis et al. 2011). This must be borne in 
mind when planning the method of reconstruction to address 
proximal tibial MBD. Higher age, poor general condition, and 
suppressed wound healing, for example by antiangiogenetic 
drugs, further increases the risk of delayed wound healing and 
subsequent infection (Carroll et al. 2014). 
This study does have its limitations. This study is retrospec-
tive, with the inherent limitations. However, to our knowledge 
this is the first study focusing on the surgical management of 
proximal tibia metastases and, despite the limited numbers, 
represents the largest cohort to date. The small numbers pre-
sented will undoubtedly result in selection bias towards the 
mechanism of reconstruction. The study does not include 
patient-related quality of life or functional outcome. Thus a 
less interventional procedure may carry a better functional 
outcome but at the risk of tumor progression and the need for 
later surgical interventions. In addition, it was not possible to 
accurately assess patient comorbidity status, which may have 
contributed to the incidence of postoperative complications. 
Clearly, this must be considered when planning the method of 
reconstruction in the treatment of MBD in the proximal tibia. 
In conclusion, this study highlights the importance of 
expected patient survival when considering the method of 
reconstruction of the proximal tibia. For patients with a limited 
prognosis estimated at 6 months, a plate osteosynthesis with 
supplemented cement should be considered. For patients with 
an expected survival in excess of 12 months, a more robust 
reconstruction should be considered. A cemented long-stem 
knee replacement provides a durable reconstruction without 
significant complications, at least in the short term. Tumor 
prosthesis require prolonged postoperative immobilization 
due to the need for reconstruction of the extensor mechanism 
using a gastrocnemius flap, and are associated with a higher 
incidence of postoperative complications when compared 
with long-stem cemented knee replacement.
Preoperative radiotherapy may increase the risk of com-
plications, particularly infection, which in the presence of an 
endoprosthesis may require amputation.
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